ATE221075T1 - Thiazolobenzoheteroringe, ihre herstellung und die sie enthaltende arzneimittel - Google Patents

Thiazolobenzoheteroringe, ihre herstellung und die sie enthaltende arzneimittel

Info

Publication number
ATE221075T1
ATE221075T1 AT98912552T AT98912552T ATE221075T1 AT E221075 T1 ATE221075 T1 AT E221075T1 AT 98912552 T AT98912552 T AT 98912552T AT 98912552 T AT98912552 T AT 98912552T AT E221075 T1 ATE221075 T1 AT E221075T1
Authority
AT
Austria
Prior art keywords
alkyl
alk
ch2oh
nr11r12
thiazolobenzohetrorings
Prior art date
Application number
AT98912552T
Other languages
English (en)
Inventor
Jean-Claude Hardy
Jean Bouquerel
Patrick Nemecek
Jean-Claude Aloup
Serge Mignani
Jean-Francois Peyronel
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of ATE221075T1 publication Critical patent/ATE221075T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
AT98912552T 1997-02-28 1998-02-26 Thiazolobenzoheteroringe, ihre herstellung und die sie enthaltende arzneimittel ATE221075T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9702436A FR2760237B1 (fr) 1997-02-28 1997-02-28 Thiazolobenzoheterocycles, leur preparation et les medicaments les contenant
PCT/FR1998/000376 WO1998038194A1 (fr) 1997-02-28 1998-02-26 Thiazolobenzoheterocycles, leur preparation et les medicaments les contenant

Publications (1)

Publication Number Publication Date
ATE221075T1 true ATE221075T1 (de) 2002-08-15

Family

ID=9504307

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98912552T ATE221075T1 (de) 1997-02-28 1998-02-26 Thiazolobenzoheteroringe, ihre herstellung und die sie enthaltende arzneimittel

Country Status (10)

Country Link
EP (1) EP0966473B1 (de)
JP (1) JP4436460B2 (de)
AT (1) ATE221075T1 (de)
AU (1) AU6734598A (de)
DE (1) DE69806734T2 (de)
DK (1) DK0966473T3 (de)
ES (1) ES2180156T3 (de)
FR (1) FR2760237B1 (de)
PT (1) PT966473E (de)
WO (1) WO1998038194A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA90269C2 (ru) * 2004-04-02 2010-04-26 Мицубиси Танабе Фарма Корпорейшн Тетрагидрохинолиновые производные и способ их получения
DE102005027168A1 (de) * 2005-06-13 2006-12-14 Merck Patent Gmbh Tetrahydrochinoline

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992378A (en) * 1973-12-26 1976-11-16 Eli Lilly And Company Fluoralkyl quinoxadinediones
JPS55111406A (en) * 1979-02-19 1980-08-28 Takeda Chem Ind Ltd Agent for controlling plant disease
DK160941C (da) * 1988-06-28 1991-10-21 Novo Nordisk As Kondenserede 2,3-dihydroxypyraziner, fremgangsmaade til deres fremstilling og farmaceutiske praeparater, hvori forbindelserne indgaar
DK0480939T3 (da) * 1989-06-09 1995-07-10 Upjohn Co Heterocycliske aminer med virkning på centralnervesystemet
PT509398E (pt) * 1991-04-15 2002-02-28 Aventis Pharma Gmbh Quinoxalinas processo para a sua preparacao e sua utilizacao
EP0705835A1 (de) * 1994-09-01 1996-04-10 Ciba-Geigy Ag Oxa- oder thiaaliphatisch überbrückte Chinoxalin-2,3-dione

Also Published As

Publication number Publication date
FR2760237B1 (fr) 1999-04-16
FR2760237A1 (fr) 1998-09-04
AU6734598A (en) 1998-09-18
ES2180156T3 (es) 2003-02-01
JP4436460B2 (ja) 2010-03-24
JP2001517214A (ja) 2001-10-02
EP0966473A1 (de) 1999-12-29
DE69806734D1 (de) 2002-08-29
DE69806734T2 (de) 2002-12-05
EP0966473B1 (de) 2002-07-24
PT966473E (pt) 2002-12-31
WO1998038194A1 (fr) 1998-09-03
DK0966473T3 (da) 2002-11-18

Similar Documents

Publication Publication Date Title
TR200402656T4 (tr) Antikanser ajanları olarak faydalı tiyofen türevleri
ES2213007T3 (es) Derivados de 4,5-diaril-3(2h)-furanona como inhibidores de la ciclooxigenasa-2.
DK1022277T3 (da) Nye taxanderivater
PA8592001A1 (es) Activadores de glocoquinasa heteroaromaticos de seis miembros 5-sustituidos
BRPI0417043A (pt) composição farmacêutica, forma de dosagem sólida, método de manufatura de forma de dosagem sólida, e, uso da composição
ATE449069T1 (de) Aminopropanolderivate
BR0115936A (pt) 2-anilino-benzimidazóis substituìdos e sua aplicação como inibidores de nhe
KR890009875A (ko) 신규 화합물
ATE254104T1 (de) 1-acyl-3-phenyl-3-(3-piperidinopropyl)piperidin derivate als für den menschlichen nk3-rezeptor selektive antagonisten
DE50202504D1 (de) Neue 4-aminofuropyrimidine und ihre verwendung
EA200300927A1 (ru) Новый способ промышленного синтеза тетрасложных эфиров 5-[бис(карбоксиметил)амино]-3-карбоксиметил-4-циано-2-тиофенкарбоновой кислоты и применение для синтеза бивалентных солей ранелиновой кислоты и их гидратов
ATE438617T1 (de) Substituierte cyclohexyl-1,4-diamin-derivate
NO20026014D0 (no) Vitamin D-derivater
BR0109483A (pt) Pró-drogas de derivados de imidazopiridina
ES2175155T3 (es) Cetoacidos aromaticos y sus derivados como inhibidores de las metaloproteinasas matriciales.
DE69806734D1 (de) Thiazolobenzoheteroringe, ihre herstellung und die sie enthaltende arzneimittel
AR021826A1 (es) COMPUESTOS DE 2- FENILPIRAN-4-ONA, PROCESOS PARA PREPARARLOS, USO DE UN COMPUESTO INTERMEDIARIO EN DICHOS, COMPOSICIoN FARMACÉUTICA QUE LOS COMPRENDE Y USO DE DICHOS COMPUESTOS Y DICHA COMPOSICIoN PARA LA FABRICACIoN DE UN MEDICAMENTO
CA1268469C (en) PESTICIDES BASED ON PHOTOACTIVE BITHIENYL
FR2525597B1 (fr) Polymethylene diamines n,n'-substituees, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
SE0300457D0 (sv) Novel compounds
BR0104353A (pt) Taxanos heterosubstituìdos com acetato c7 como agentes antitumor
HRP20050667A2 (en) Corbonyl-amino substituted acyl phenyl urea derivatives, method for the production and use thereof
TW200505892A (en) Substituted 3-(benzoylureido)thiophene derivatives, processes for preparing them and their use
BR0108002A (pt) Derivados de amidas heterocìclicas
CY1105972T1 (el) ΝΕΑ ΥΠΟΚΑΤΕΣΤΗΜΕΝΑ ΠΑΡΑΓΩΓΑ [1,4] ΒΕΝΖΟΔΙΟΞΙΝΟ [2,3-e] ΙΣΟΪΝΔΟΛΙΟΥ, ΜΕΘΟΔΟΣ ΠΑΡΑΣΚΕΥΗΣ ΑΥΤΩΝ ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΣΥΝΘΕΣΕΙΣ ΠΟΥ ΤΑ ΠEPΙΕΧΟΥΝ